Е. А. Семенова

713 total citations
37 papers, 540 citations indexed

About

Е. А. Семенова is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Е. А. Семенова has authored 37 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 14 papers in Molecular Biology and 8 papers in Virology. Recurrent topics in Е. А. Семенова's work include HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (8 papers) and Biochemical and Molecular Research (6 papers). Е. А. Семенова is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (8 papers) and Biochemical and Molecular Research (6 papers). Е. А. Семенова collaborates with scholars based in Russia, United States and Australia. Е. А. Семенова's co-authors include Yves Pommier, Christophe Marchand, Allison A. Johnson, Robert Craigie, Dragan Maric, Paul Warrener, Gregory B. Carey, David A. Davis, Terrence R. Burke and Xiulan Qi and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Е. А. Семенова

30 papers receiving 529 citations

Peers

Countries citing papers authored by Е. А. Семенова

Since Specialization

Citations

This map shows the geographic impact of Е. А. Семенова's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Е. А. Семенова with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Е. А. Семенова more than expected).

Fields of papers citing papers by Е. А. Семенова

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Е. А. Семенова. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Е. А. Семенова. The network helps show where Е. А. Семенова may publish in the future.

Co-authorship network of co-authors of Е. А. Семенова

This figure shows the co-authorship network connecting the top 25 collaborators of Е. А. Семенова. A scholar is included among the top collaborators of Е. А. Семенова based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Е. А. Семенова. Е. А. Семенова is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structure of ClfA002 in Complex With Neutralizing Antibody AZD7745 Provides Insight into Its Broad Neutralization Mechanism in Staphylococcus aureus Infection 2025 ·The Journal of Infectious Diseases ·Christine Tkaczyk, Tal Keren‐Kaplan, (unknown), Paul Warrener, Е. А. Семенова, (unknown), Arnita Barnes, (unknown), Bret R. Sellman, Ondřej Podlaha, Vaheh Oganesyan	0
2	Modern understanding of adult celiac disease 2021 ·Experimental and Clinical Gastroenterology ·(unknown), И. Г. Бакулин, (unknown), Е. А. Семенова, С. И. Ситкин	1
3	Diet therapy for irritable bowel syndrome 2020 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), С. И. Ситкин, (unknown), (unknown), Е. А. Семенова	3
4	Functional disorders of motor activity of the digestive tract and their osteopathic correction in patients with celiac disease 2019 ·Experimental and Clinical Gastroenterology ·(unknown), (unknown), P. Seliverstov, Е. А. Семенова, (unknown), (unknown)	3
5	Alanine Scanning Mutagenesis of the MEDI4893 (Suvratoxumab) Epitope Reduces Alpha Toxin Lytic Activity In Vitro and Staphylococcus aureus Fitness in Infection Models 2018 ·Antimicrobial Agents and Chemotherapy ·Christine Tkaczyk, Е. А. Семенова, Yuru Shi, (unknown), Vaheh Oganesyan, Paul Warrener, (unknown), Bret R. Sellman	17
6	Activity and Electrophoretic Spectra of Enzymes in Soy Leaves Affected by the Pathogens of Various Trophic Groups 2018 ·Russian Agricultural Sciences ·Е. А. Семенова, (unknown), (unknown), (unknown)	1
7	Anti-LPS antibodies protect against Klebsiella pneumoniae by empowering neutrophil-mediated clearance without neutralizing TLR4 2017 ·JCI Insight ·Taylor S. Cohen, Mark Pelletier, Lily Cheng, Meghan E. Pennini, Jessica Bonnell, (unknown), (unknown), Xiaodong Xiao, Elisabetta Cameroni, Davide Corti, Е. А. Семенова, Paul Warrener, Bret R. Sellman, JoAnn Suzich, Qun Wang, C. Kendall Stover	36
8	Частота и факторы риска ишемической болезни сердца при хронической фтористой интоксикации 2014 ·Complex Issues of Cardiovascular Diseases ·(unknown), Е. А. Семенова, (unknown), (unknown), (unknown)	1
9	Modification of Ad5 Hexon Hypervariable Regions Circumvents Pre-Existing Ad5 Neutralizing Antibodies and Induces Protective Immune Responses 2012 ·PLoS ONE ·Joseph T. Bruder, Е. А. Семенова, Ping Chen, Keith Limbach, Noelle B. Patterson, (unknown), Svetlana Konovalova, (unknown), Melissa Hamilton, C. Richter King, Thomas L. Richie, Denise L. Doolan	30
10	A pseudovirus system for the testing of antiviral activity of compounds in different cell lines 2010 ·Doklady Biochemistry and Biophysics ·(unknown), (unknown), Е. А. Семенова, Vladimir O. Pustylnyak, В. В. Власов, Аndrey G. Pokrovsky	4
11	HIV‐1 Integrase Inhibitors: Update and Perspectives 2008 ·Advances in pharmacology ·Е. А. Семенова, Christophe Marchand, Yves Pommier	36
12	IL-4 protects the B-cell lymphoma cell line CH31 from anti-IgM-induced growth arrest and apoptosis: contribution of the PI-3 kinase/AKT pathway 2007 ·Cell Research ·Gregory B. Carey, Е. А. Семенова, Xiulan Qi, Achsah Keegan	33
13	Preferential Inhibition of the Magnesium-Dependent Strand Transfer Reaction of HIV-1 Integrase by α-Hydroxytropolones 2006 ·Molecular Pharmacology ·Е. А. Семенова, Allison A. Johnson, Christophe Marchand, David A. Davis, Robert Yarchoan, Yves Pommier	50
14	Integration of human immunodeficiency virus as a target for antiretroviral therapy 2006 ·Current Opinion in HIV and AIDS ·Е. А. Семенова, Allison A. Johnson, Christophe Marchand, Yves Pommier	6
15	Synthesis and HIV-1 integrase inhibitory activity of spiroundecane(ene) derivatives 2006 ·Bioorganic & Medicinal Chemistry Letters ·Elvira E. Shults, Е. А. Семенова, Allison A. Johnson, (unknown), Irina Yu. Bagryanskaya, Yu. V. Gatilov, Genrikh A. Tolstikov, Yves Pommier	24
16	Biotinylated biphenyl ketone-containing 2,4-dioxobutanoic acids designed as HIV-1 integrase photoaffinity ligands 2006 ·Bioorganic & Medicinal Chemistry ·Xue Zhi Zhao, Е. А. Семенова, Chenzhong Liao, Marc C. Nicklaus, Yves Pommier, Terrence R. Burke	18
17	Mechanisms and inhibition of HIV integration 2006 ·Drug Discovery Today Disease Mechanisms ·Christophe Marchand, Allison A. Johnson, Е. А. Семенова, Yves Pommier	23
18	Characterization of Recombinant Integrase of Human Immunodeficiency Virus Type 1 (Isolate Bru) 2003 ·Biochemistry (Moscow) ·Е. А. Семенова, (unknown), Tatiana V. Ilina, (unknown), Аndrey G. Pokrovsky	1
19	Inhibition of the Activity of Recombinant HIV-1 Integrase by Derivatives of Higher Terpenoids 2003 ·Doklady Biochemistry and Biophysics ·Е. А. Семенова, (unknown), (unknown), (unknown), Elvira E. Shults, Г. А. Толстиков, А. Г. Покровский	2
20	Inhibition of HIV-1 Reverse Transcriptase by Aryl-Substituted Naphto- and Anthraquinones 2002 ·Doklady Biochemistry and Biophysics ·Tatiana V. Ilina, Е. А. Семенова, (unknown), А. Г. Покровский, (unknown), Elvira E. Shults, (unknown), Sergey N. Kochetkov, Г. А. Толстиков	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact